Australia - engelsk - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 9 g/l; glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as solvent for intravenously administered drugs where compatibility has been established.

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ardeapharma, a.s., Ševětín array - 1322 chlorid sodnÝ; 1174 chlorid draselnÝ; 235 chlorid vÁpenatÝ; 856 hexahydrÁt chloridu hoŘeČnatÉho; 1334 natrium-laktÁt; 663 glukosa; 366 monohydrÁt kyseliny citronovÉ; 2467 disiŘiČitan sodnÝ - infuzní roztok - elektrolyty se sacharidy

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

b. braun melsungen aktiengesellschaft (3049484) - natriumchlorid - konzentrat zur herstellung einer infusionslösung - teil 1 - konzentrat zur herstellung einer infusionslösung; natriumchlorid (00211) 11,7 gramm

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

fresenius kabi s.r.o., praha array - 1322 chlorid sodnÝ; 1174 chlorid draselnÝ; 5599 dihydrÁt chloridu vÁpenatÉho; 856 hexahydrÁt chloridu hoŘeČnatÉho; 1306 trihydrÁt natrium-acetÁtu; 4957 monohydrÁt glukosy - infuzní roztok - elektrolyty se sacharidy

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

fresenius kabi s.r.o., praha array - 1306 trihydrÁt natrium-acetÁtu; 1322 chlorid sodnÝ; 1174 chlorid draselnÝ; 856 hexahydrÁt chloridu hoŘeČnatÉho - infuzní roztok - elektrolyty

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - ropivacaine hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - ropivacaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - ropivacaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ardeapharma, a.s., Ševětín array - 1322 chlorid sodnÝ; 1174 chlorid draselnÝ; 2776 hexahydrÁt chloridu vÁpenatÉho; 856 hexahydrÁt chloridu hoŘeČnatÉho; 1306 trihydrÁt natrium-acetÁtu - infuzní roztok - elektrolyty

Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

ardeapharma, a.s., Ševětín array - 1322 chlorid sodnÝ; 1174 chlorid draselnÝ; 2776 hexahydrÁt chloridu vÁpenatÉho; 856 hexahydrÁt chloridu hoŘeČnatÉho; 1334 natrium-laktÁt - infuzní roztok - elektrolyty